|
|
|
|
||
Re: why no news?-RubraI am hoping the Precigen partners its Adenoverse platform for rare disease opportunities. Repeat dosing and large payloads are what is needed by gene therapy companies and it seems Precigen have it. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
40114 | Re: why no news?-Rubra | captkerosene | 0 | 5/22/2020 12:13:09 PM |